Personal information

United Kingdom

Biography

I am an experienced researcher with extensive knowledge in Biomedical Science, particularly in Pre-Clinical Oncology. Throughout my academic career, I have collaborated with experts from various disciplines to acquire new skills and address emerging challenges. My skill set includes expertise in cell culture, 3D modelling, and cancer molecular biology. Additionally, I have industry experience, where I have been involved in project design, experimental planning, and data analysis and interpretation.

I hold a PhD in Pre-Clinical Oncology, a Master's degree in Biomedicine and a Bachelor's degree in Biochemistry and Molecular Biology. I am always looking for the opportunity to learn new things, gain new experiences which will ultimately support my own self-development.

Activities

Employment (3)

HistologiX: Nottingham, GB

2023-12 to present | Client Manager
Employment
Source: Self-asserted source
Mireia Sueca-Comes

Cellomatics Biosciences Ltd: Nottingham, GB

2023-05 to 2023-11 | Bioassay Scientist
Employment
Source: Self-asserted source
Mireia Sueca-Comes

University of Nottingham: Nottingham, GB

2022-02 to 2023-05 | Scientific Researcher (Biodiscovery Institute)
Employment
Source: Self-asserted source
Mireia Sueca-Comes

Education and qualifications (3)

University of Nottingham: Nottingham, GB

2018-09 to 2022-11 | PhD in Pre-Clinical Oncology
Education
Source: Self-asserted source
Mireia Sueca-Comes

Universitat de Barcelona: Barcelona, ES

2017-10 to 2018-07 | Biomedicine MSc
Education
Source: Self-asserted source
Mireia Sueca-Comes

Universitat Rovira i Virgili: Tarragona, ES

2013-09 to 2017-06 | Biochemistry and Molecular Biology BSc
Education
Source: Self-asserted source
Mireia Sueca-Comes

Works (4)

The role of mesenchymal cells in cholangiocarcinoma

Disease Models & Mechanisms
2024-12-01 | Journal article
Contributors: Mireia Sueca-Comes; Elena Cristina Rusu; Jennifer C. Ashworth; Pamela Collier; Catherine Probert; Alison Ritchie; Marian Meakin; Nigel P. Mongan; Isioma U. Egbuniwe; Jesper Bøje Andersen et al.
Source: check_circle
Crossref

Preclinical evidence for anaplastic lymphoma kinase inhibitors as novel therapeutic treatments for cholangiocarcinoma

Frontiers in Oncology
2023-12-07 | Journal article
Part of ISSN: 2234-943X
Contributors: Kyaw Zwar Myint; Mireia Sueca-Comes; Pamela Collier; Brinda Balasubramanian; Simran Venkatraman; John Gordan; Abed M. Zaitoun; Abhik Mukherjee; Arvind Arora; Noppadol Larbcharoensub et al.
Source: Self-asserted source
Mireia Sueca-Comes

Looking Under the Lamppost: The Search for New Cancer Targets in the Human Kinome.

Pharmacological reviews
2022-10-01 | Journal article
Contributors: Sueca-Comes M; Elena Cristina Rusu Hutu; Anna Grabowska; Bates DO
Source: Self-asserted source
Mireia Sueca-Comes

CD10 inhibits cell motility but expression is associated with advanced stage disease in colorectal cancer.

Experimental and molecular pathology
2018-04-11 | Journal article
Contributors: Raposo, TP; Comes MS; Idowu A; Agit B; Hassall J; Wakkas Fadhil; Nica R; Rupert C. Ecker; Yao T; Ilyas M
Source: Self-asserted source
Mireia Sueca-Comes
grade
Preferred source (of 2)‎